138 related articles for article (PubMed ID: 16354329)
1. T-cell prolymphocytic leukemia: a single-institution experience.
Ravandi F; O'Brien S; Jones D; Lerner S; Faderl S; Ferrajoli A; Wierda W; Garcia-Manero G; Thomas D; Koller C; Verstovsek S; Giles F; Cortes J; Herling M; Kantarjian H; Keating M
Clin Lymphoma Myeloma; 2005 Nov; 6(3):234-9. PubMed ID: 16354329
[TBL] [Abstract][Full Text] [Related]
2. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
Magro CM; Morrison CD; Heerema N; Porcu P; Sroa N; Deng AC
J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
[TBL] [Abstract][Full Text] [Related]
3. [Cutaneous localization of T-cell prolymphocytic leukemia].
Thomas A; Dompmartin A; Troussard X; Moreau A; Manard C; Leroy D
Ann Dermatol Venereol; 1995; 122(8):526-9. PubMed ID: 8572493
[TBL] [Abstract][Full Text] [Related]
4. Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32).
Dürig J; Bug S; Klein-Hitpass L; Boes T; Jöns T; Martin-Subero JI; Harder L; Baudis M; Dührsen U; Siebert R
Leukemia; 2007 Oct; 21(10):2153-63. PubMed ID: 17713554
[TBL] [Abstract][Full Text] [Related]
5. T-cell prolymphocytic leukemia frequently shows cutaneous involvement and is associated with gains of MYC, loss of ATM, and TCL1A rearrangement.
Hsi AC; Robirds DH; Luo J; Kreisel FH; Frater JL; Nguyen TT
Am J Surg Pathol; 2014 Nov; 38(11):1468-83. PubMed ID: 25310835
[TBL] [Abstract][Full Text] [Related]
6. TCL1 is overexpressed in patients affected by adult T-cell leukemias.
Narducci MG; Stoppacciaro A; Imada K; Uchiyama T; Virgilio L; Lazzeri C; Croce CM; Russo G
Cancer Res; 1997 Dec; 57(24):5452-6. PubMed ID: 9407948
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic characterization of T-cell prolymphocytic leukemia.
Chen X; Cherian S
Am J Clin Pathol; 2013 Nov; 140(5):727-35. PubMed ID: 24124154
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic studies on prolymphocytic leukemia. 1. B-cell prolymphocytic leukemia.
Brito-Babapulle V; Pittman S; Melo JV; Pomfret M; Catovsky D
Hematol Pathol; 1987; 1(1):27-33. PubMed ID: 3509770
[TBL] [Abstract][Full Text] [Related]
9. Mature T-cell leukemias.
Ravandi F; Kantarjian H; Jones D; Dearden C; Keating M; O'Brien S
Cancer; 2005 Nov; 104(9):1808-18. PubMed ID: 16136598
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia.
Hu Z; Medeiros LJ; Fang L; Sun Y; Tang Z; Tang G; Sun T; Quesada AE; Hu S; Wang SA; Pei L; Lu X
Am J Hematol; 2017 May; 92(5):441-447. PubMed ID: 28194886
[TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia.
Matutes E; Brito-Babapulle V; Swansbury J; Ellis J; Morilla R; Dearden C; Sempere A; Catovsky D
Blood; 1991 Dec; 78(12):3269-74. PubMed ID: 1742486
[TBL] [Abstract][Full Text] [Related]
12. IL-2-induced growth of CD8+ T cell prolymphocytic leukemia cells mediated by NF-kappaB induction and IL-2 receptor alpha expression.
Arima N; Matsushita K; Suruga Y; Ohtsubo H; Fujiwara H; Hidaka S; Arimura K; Kukita T; Yamaguchi K; Fukumori J; Tanaka H
Leuk Res; 1998 Mar; 22(3):265-73. PubMed ID: 9619918
[TBL] [Abstract][Full Text] [Related]
13. T-cell prolymphocytic leukemia involving extramedullary sites.
Valbuena JR; Herling M; Admirand JH; Padula A; Jones D; Medeiros LJ
Am J Clin Pathol; 2005 Mar; 123(3):456-64. PubMed ID: 15716243
[TBL] [Abstract][Full Text] [Related]
14. T gamma lymphocytosis and T cell chronic leukemias.
Berliner N
Hematol Oncol Clin North Am; 1990 Apr; 4(2):473-87. PubMed ID: 2182603
[TBL] [Abstract][Full Text] [Related]
15. Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.
Hopfinger G; Busch R; Pflug N; Weit N; Westermann A; Fink AM; Cramer P; Reinart N; Winkler D; Fingerle-Rowson G; Stilgenbauer S; Döhner H; Kandler G; Eichhorst B; Hallek M; Herling M
Cancer; 2013 Jun; 119(12):2258-67. PubMed ID: 23512246
[TBL] [Abstract][Full Text] [Related]
16. Translocation (8;14)(q24;q32) as the sole cytogenetic abnormality in B-cell prolymphocytic leukemia.
Kuriakose P; Perveen N; Maeda K; Wiktor A; Van Dyke DL
Cancer Genet Cytogenet; 2004 Apr; 150(2):156-8. PubMed ID: 15066324
[TBL] [Abstract][Full Text] [Related]
17. Multiple karyotypic abnormalities in three cases of small cell variant of T-cell prolymphocytic leukemia.
Heinonen K; Mahlamäki E; Hämäläinen E; Nousiainen T; Mononen I
Cancer Genet Cytogenet; 1994 Nov; 78(1):28-35. PubMed ID: 7987802
[TBL] [Abstract][Full Text] [Related]
18. How I treat prolymphocytic leukemia.
Dearden C
Blood; 2012 Jul; 120(3):538-51. PubMed ID: 22649104
[TBL] [Abstract][Full Text] [Related]
19. Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Français d'Hématologie Cellulaire.
Garand R; Goasguen J; Brizard A; Buisine J; Charpentier A; Claisse JF; Duchayne E; Lagrange M; Segonds C; Troussard X; Flandrin G
Br J Haematol; 1998 Nov; 103(2):488-94. PubMed ID: 9827924
[TBL] [Abstract][Full Text] [Related]
20. Histopathology of the spleen in T-cell large granular lymphocyte leukemia and T-cell prolymphocytic leukemia: a comparative review.
Osuji N; Matutes E; Catovsky D; Lampert I; Wotherspoon A
Am J Surg Pathol; 2005 Jul; 29(7):935-41. PubMed ID: 15958859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
